CNTX
Price
$0.60
Change
-$0.01 (-1.64%)
Updated
Jul 31 closing price
Capitalization
55.07M
9 days until earnings call
Intraday BUY SELL Signals
NMRA
Price
$1.61
Change
-$0.04 (-2.42%)
Updated
Jul 31 closing price
Capitalization
298.31M
9 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTX vs NMRA

CNTX vs NMRA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CNTX vs. NMRA commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Hold and NMRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (CNTX: $0.60 vs. NMRA: $1.61)
Brand notoriety: CNTX and NMRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 25% vs. NMRA: 46%
Market capitalization -- CNTX: $55.07M vs. NMRA: $298.31M
CNTX [@Biotechnology] is valued at $55.07M. NMRA’s [@Biotechnology] market capitalization is $298.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whileNMRA’s FA Score has 1 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • NMRA’s FA Score: 1 green, 4 red.
According to our system of comparison, both CNTX and NMRA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 4 TA indicator(s) are bullish while NMRA’s TA Score has 5 bullish TA indicator(s).

  • CNTX’s TA Score: 4 bullish, 5 bearish.
  • NMRA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NMRA is a better buy in the short-term than CNTX.

Price Growth

CNTX (@Biotechnology) experienced а -2.39% price change this week, while NMRA (@Biotechnology) price change was +8.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

CNTX is expected to report earnings on Aug 12, 2026.

NMRA is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NMRA($298M) has a higher market cap than CNTX($55.1M). NMRA YTD gains are higher at: -10.056 vs. CNTX (-59.224). CNTX has higher annual earnings (EBITDA): -43.5M vs. NMRA (-217.21M). NMRA has more cash in the bank: 147M vs. CNTX (54.5M). CNTX has less debt than NMRA: CNTX (282K) vs NMRA (53.4M). CNTX (0) and NMRA (0) have equivalent revenues.
CNTXNMRACNTX / NMRA
Capitalization55.1M298M18%
EBITDA-43.5M-217.21M20%
Gain YTD-59.224-10.056589%
P/E RatioN/AN/A-
Revenue00-
Total Cash54.5M147M37%
Total Debt282K53.4M1%
TECHNICAL ANALYSIS
Technical Analysis
CNTXNMRA
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
87%
Momentum
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 8 days ago
90%
Bullish Trend 7 days ago
88%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 13 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
74%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CNTX
Daily Signal:
Gain/Loss:
NMRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ITHVX61.940.37
+0.60%
Hartford Capital Appreciation R6
PEGGX20.590.05
+0.24%
PGIM Jennison Mid-Cap Growth R4
AMDWX17.700.01
+0.06%
Amana Developing World Investor
FAMEX55.74-0.38
-0.68%
FAM Dividend Focus Fund Investor
RYCMX55.80-0.43
-0.76%
Rydex Russell 2000 1.5x Strategy C

NMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NMRA has been loosely correlated with SLBT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NMRA jumps, then SLBT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMRA
1D Price
Change %
NMRA100%
-2.42%
SLBT - NMRA
43%
Loosely correlated
-1.67%
CNTX - NMRA
42%
Loosely correlated
-1.30%
SNDX - NMRA
35%
Loosely correlated
-2.21%
ADCT - NMRA
33%
Poorly correlated
-5.41%
CRVO - NMRA
33%
Poorly correlated
+2.38%
More